These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 8041200

  • 41. The multifactorial origin of growth failure in thalassaemia.
    Skordis N, Kyriakou A.
    Pediatr Endocrinol Rev; 2011 Mar; 8 Suppl 2():271-7. PubMed ID: 21705977
    [Abstract] [Full Text] [Related]

  • 42. [German multicenter thalassemia study. Concept and initial results].
    Kohne E, Stahnke K, Kulozik AE, Kleihauer E.
    Klin Padiatr; 1992 Mar; 204(4):258-63. PubMed ID: 1518262
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Growth and development in thalassaemia major patients with severe bone lesions due to desferrioxamine.
    De Sanctis V, Pinamonti A, Di Palma A, Sprocati M, Atti G, Gamberini MR, Vullo C.
    Eur J Pediatr; 1996 May; 155(5):368-72. PubMed ID: 8741032
    [Abstract] [Full Text] [Related]

  • 46. Growth, puberty and endocrine function in beta-thalassaemia major.
    Low LC.
    J Pediatr Endocrinol Metab; 1997 May; 10(2):175-84. PubMed ID: 9364350
    [Abstract] [Full Text] [Related]

  • 47. Clinical and histological results of long-term management of aluminium overloading in uraemic patients with desferrioxamine.
    Canavese C, Pacitti A, Segoloni G, Thea A, D'Amicone M, Stratta P, Rossi P, Sabbioni E, Pietra R, Constantini S.
    J Trace Elem Electrolytes Health Dis; 1989 Mar; 3(1):17-23. PubMed ID: 2535315
    [Abstract] [Full Text] [Related]

  • 48. Early iron chelation therapy in thalassemia major.
    Russo G, Romeo MA, Musumeci S, Schilirò G, Di Gregorio F.
    Haematologica; 1983 Mar; 68(1):69-73. PubMed ID: 6404710
    [No Abstract] [Full Text] [Related]

  • 49. [Recommendations for therapy of juvenile thalassemia major].
    Siller V, Frank M.
    Fortschr Med; 1980 Nov 27; 98(44):1720-9. PubMed ID: 7007189
    [Abstract] [Full Text] [Related]

  • 50. Continuous desferrioxamine infusion by an infusor in thalassaemia major.
    Canatan D, Temimhan N, Dinçer N, Ozsancak A, Oğuz N, Temimhan M.
    Acta Paediatr; 1999 May 27; 88(5):550-2. PubMed ID: 10426179
    [Abstract] [Full Text] [Related]

  • 51. Survival in beta-thalassaemia major in the UK: data from the UK Thalassaemia Register.
    Modell B, Khan M, Darlison M.
    Lancet; 2000 Jun 10; 355(9220):2051-2. PubMed ID: 10885361
    [Abstract] [Full Text] [Related]

  • 52. Sensorineural hearing loss in children with thalassemia major in Northern Greece.
    Kontzoglou G, Koussi A, Tsatra J, Noussios G, Vital V, Sagarakis G, Athanassiou M.
    Int J Pediatr Otorhinolaryngol; 1996 May 10; 35(3):223-30. PubMed ID: 8762595
    [Abstract] [Full Text] [Related]

  • 53. Growth plate injury of the long bones in treated beta-thalassemia.
    Orzincolo C, Scutellari PN, Castaldi G.
    Skeletal Radiol; 1992 May 10; 21(1):39-44. PubMed ID: 1546335
    [Abstract] [Full Text] [Related]

  • 54. Clinical manifestations and therapy of transfusional haemosiderosis.
    Gabutti V, Borgna-Pignatti C.
    Baillieres Clin Haematol; 1994 Dec 10; 7(4):919-40. PubMed ID: 7881160
    [Abstract] [Full Text] [Related]

  • 55. Decreased expression of c-myc oncoprotein by peripheral blood mononuclear cells in thalassaemia patients receiving desferrioxamine.
    Kyriakou D, Eliopoulos AG, Papadakis A, Alexandrakis M, Eliopoulos GD.
    Eur J Haematol; 1998 Jan 10; 60(1):21-7. PubMed ID: 9451424
    [Abstract] [Full Text] [Related]

  • 56. Deferoxamine-induced bone dysplasia in patients with thalassemia major.
    Brill PW, Winchester P, Giardina PJ, Cunningham-Rundles S.
    AJR Am J Roentgenol; 1991 Mar 10; 156(3):561-5. PubMed ID: 1899759
    [Abstract] [Full Text] [Related]

  • 57. Value of sequential monitoring of left ventricular ejection fraction in the management of thalassemia major.
    Davis BA, O'Sullivan C, Jarritt PH, Porter JB.
    Blood; 2004 Jul 01; 104(1):263-9. PubMed ID: 15001468
    [Abstract] [Full Text] [Related]

  • 58. Relationship of endocrinopathy to iron chelation status in young patients with thalassaemia major.
    Grundy RG, Woods KA, Savage MO, Evans JP.
    Arch Dis Child; 1994 Aug 01; 71(2):128-32. PubMed ID: 7944532
    [Abstract] [Full Text] [Related]

  • 59. Morbidity and mortality of iron intoxication in adult patients with thalassemia major, and effectiveness of chelation.
    Ladis V, Berdousi H, Palamidou F, Agrafioti C, Papadopoulou A, Anagnostopoulos G, Theodorides C, Kattamis C.
    Transfus Sci; 2000 Dec 01; 23(3):255-6. PubMed ID: 11099908
    [No Abstract] [Full Text] [Related]

  • 60. MR imaging of deferoxamine-induced bone dysplasia in an 8-year-old female with thalassemia major.
    Miller TT, Caldwell G, Kaye JJ, Arkin S, Burke S, Brill PW.
    Pediatr Radiol; 1993 Dec 01; 23(7):523-4. PubMed ID: 8309753
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.